Prospective multicEntric NonranDomized Registry

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT02496169

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Eucatech AG (from the registry)
Registry
  • NCT NCT02496169
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02496169. Non-randomized; no masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective multicEntric NonranDomized Registry
Acronym
ExPEND
Intervention (Device)
eucaLimus
Lead sponsor
Eucatech AG (class: industry)
Collaborator
CERES GmbH (class: industry)

Record details

Record id
cardio:ct-nct02496169
Content hash
8c13bbc0debd66d3d84f602bacaa1c19c3c727c1d1b1fc648e867d0b220cd06d